poisar

Stocks · News reference

BTIG Terminates Sales Agreement With Matinas BioPharma, Effective Immediately On July 23; Incurs No Termination Penalties Or Expenses From Sales Agreement Termination

BenzingaJul 24, 2026, 9:11 PMBenzinga Newsdesk

As previously disclosed, on July 2, 2020, Matinas BioPharma Holdings, Inc. (the "Company") entered into an At-The-Market Sales Agreement (the "Sales Agreement") with BTIG, LLC ("BTIG"), pursuant

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Jul 24, 2026, 9:11 PM
Checked
Jul 24, 2026, 9:11 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading